618 related articles for article (PubMed ID: 12368162)
1. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
2. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
5. High levels of coagulation factor XI as a risk factor for venous thrombosis.
Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
7. Incidence of venous thromboembolism in families with inherited thrombophilia.
Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
9. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
Kraaijenhagen RA; in't Anker PS; Koopman MM; Reitsma PH; Prins MH; van den Ende A; Büller HR
Thromb Haemost; 2000 Jan; 83(1):5-9. PubMed ID: 10669145
[TBL] [Abstract][Full Text] [Related]
10. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
11. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
12. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
[TBL] [Abstract][Full Text] [Related]
14. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
15. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
[TBL] [Abstract][Full Text] [Related]
17. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
19. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
20. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
